Stocks TradingCharts.com

stocks prices, charts & quotes

Free Stock Prices, Charts & Stock Price Quotes

Search
Symbol Search Browse Symbols My Charts Menu
QUICK QUOTE
QUICK CHART
F.A.Questions Suggestion Box Advertising Info Commodity Charts Forex Markets

Stocks & Financial News

Breaking financial news 24/7 courtesy of TradingCharts.com Inc. / TFC Commodity Charts

ASML LAWSUIT DEADLINE: BFA Law Alerts ASML Holding N.V. Investors Of Imminent January 13 Class Action Deadline Contact The Firm If You Lost Money (NASDAQ:ASML)

Jan 05, 2025 (MENAFN via COMTEX) --
(MENAFN - EIN Presswire) NEW YORK, Jan. 05, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that it has filed a class action lawsuit for violations of the federal securities laws against ASML Holding N.V. (NASDAQ: ASML) and certain of the Company's senior executives.

If you invested in ASML, you are encouraged to obtain additional information by visiting .

Investors have until January 13, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in ASML ordinary shares, call options, and/or put options. The case is pending in the U.S. District Court for the Southern District of New York and is captioned Matar v. ASML Holding N.V., et al., No. 24-cv-9908.

What is the Lawsuit About?

ASML is a leading supplier to the semiconductor industry, providing photolithography machines to chipmakers that are used in the semiconductor fabrication process.

The complaint alleges that ASML repeatedly represented to shareholders that new export controls on semiconductor technology announced by the Dutch government would not have a material effect on ASML's financial outlook, and that ASML was on a path to recovery in its sales.

On October 15, 2024, ASML announced earnings significantly lower than expectations. The Company attributed this to a market that was"taking longer to recover" and admitted that"[i]t now appears the recovery is more gradual than previously expected." On this news, the price of the Company's stock fell 16%, from a closing price of $872.27 per share on October 14, 2024, to $730.43 per share on October 15, 2024.

Then, during the accompanying earnings call with investors on October 16, 2024, the Company attributed the poor earnings results to"a reflection of the slow recovery in the traditional [semiconductor] end markets as customers remain cautious in the current environment." The Company also disclosed that the decline in ASML's sales to China would also negatively impact the Company's gross margins. On this news, the price of the Company's stock fell 6.4%, from a closing price of $730.43 per share on October 15, 2024, to $683.52 per share on October 16, 2024.

Click here if you suffered losses: .

What Can You Do?

If you invested in ASML you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:

Or contact:
Ross Shikowitz
...
212-789-3619

Why Bleichmar Fonti & Auld LLP?

Bleichmar Fonti & Auld LLP is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It was named among the Top 5 plaintiff law firms by ISS SCAS in 2023 and its attorneys have been named Titans of the Plaintiffs' Bar by Law360 and SuperLawyers by Thompson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.'s Board of Directors (pending court approval), as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit .

Attorney advertising. Past results do not guarantee future outcomes.


-p

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

MENAFN05012025003118003196ID1109056416

comtex tracking

COMTEX_461574540/2604/2025-01-05T18:11:52

Do not sell my personal information

Copyright © 2025. All market data is provided by Barchart Solutions. Information is provided "as is" and solely for informational purposes, not for trading purposes or advice. To see all exchange delays and terms of use, please see disclaimer.